CCSC

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

Managed Care Considerations on Facilitating the Timely Diagnosis and Evidence-Based Treatment of von Willebrand Disease

Part I: Evidence-Based Diagnostic and Management Approaches for VWD

Featuring

Angela Weyand, MD

Angela Weyand, MD
Assistant Clinical Professor
University of Michigan School of Medicine
C. S. Mott Children’s Hospital

 

Part II: Optimizing Clinical and Economic Outcomes in the Management of VWD

Featuring

Maria Lopes, MD
Former Chief Medical Officer
Magellan Health

 

Part III: Managed Care Case Studies in VWD

Featuring

Maria Lopes, MD
Former Chief Medical Officer
Magellan Health		 Angela Weyand, MD Angela Weyand, MD
Assistant Clinical Professor
University of Michigan School of Medicine
C. S. Mott Children’s Hospital

 

 

 

 

Jointly provided by

Jointly provided by

    

  • CCSC is supported by charitable donations from founding supporter Takeda, and additional support from BioMarin, Biotechnology Innovation Organization, Bleeding & Clotting Disorders Institute, CSL Behring, Genentech, Inc., Gulf States Hemophilia and Thrombophilia Center, Louisiana Center for Bleeding and Clotting Disorders, Sanofi, and Spark Therapeutics.

  • Copay Accumulator Adjustment Program (CAAP) Outreach is supported by AbbVie, Inc.

    © 2023 National Hemophilia Foundation. All rights reserved.

 

Footer Menu